NYSE:AGL
agilon health, inc.
agilon health, inc.'s revenue fell 2.1% in fiscal 2025 to $5.9B while operating margin fell to −7.8%. Free cash flow was −$119.0M, −2.0% of revenue, and the diluted share count rose 0.7%.Summary generated from agilon health, inc.'s SEC filings. Latest annual report filed Feb 25, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$5.9B
Revenue growth−2.1%
Revenue, 5-yr CAGR+37.2%
Gross marginn/a
Operating margin−7.8%
Net margin−6.6%
ROIC−239.5%
Return on equity−131.0%
Debt / equity0.28
Free cash flow−$119.0M
FCF margin−2.0%
Share count change+0.7%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1,521 | 2,388 | 4,316 | 6,061 | 5,933 |
| Operating income | −372 | −105 | −232 | −292 | −463 |
| Net income | −406 | −107 | −263 | −260 | −391 |
| Free cash flow | −155 | −146 | −172 | −71 | −119 |
Recent filings
- 4Insider transaction report
Aug 18, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 5, 2026 - 4Insider transaction report
Aug 4, 2026 - 8-KDirector or officer change
Jul 22, 2026 - 8-KResults of a shareholder vote
Jun 3, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 6, 2026 - 8-KResults of operations and financial condition
May 6, 2026